Egesta Lopci, MD, PhD
Egesta Lopci, MD, PhD
Nuclear Medicine, Humanitas Clinical and Research Hospital
Dirección de correo verificada de humanitas.it - Página principal
Título
Citado por
Citado por
Año
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence
E Lopci, I Grassi, A Chiti, C Nanni, G Cicoria, L Toschi, C Fonti, F Lodi, ...
American journal of nuclear medicine and molecular imaging 4 (4), 365, 2014
1562014
Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review
AM Maffione, E Lopci, C Bluemel, F Giammarile, K Herrmann, D Rubello
European journal of nuclear medicine and molecular imaging 42 (1), 152-163, 2015
952015
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study
A Piccardo, E Lopci, M Conte, A Garaventa, L Foppiani, V Altrinetti, ...
European journal of nuclear medicine and molecular imaging 39 (1), 57-71, 2012
932012
High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors
J Brummelman, E Mazza, G Alvisi, FS Colombo, A Grilli, J Mikulak, ...
Journal of Experimental Medicine 215 (10), 2520-2535, 2018
702018
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …
I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ...
European journal of nuclear medicine and molecular imaging 46 (3), 540-557, 2019
652019
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
E Lopci, L Toschi, F Grizzi, D Rahal, L Olivari, GF Castino, S Marchetti, ...
European journal of nuclear medicine and molecular imaging 43 (11), 1954-1961, 2016
582016
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma
N Quartuccio, G Treglia, M Salsano, MV Mattoli, B Muoio, A Piccardo, ...
Radiology and Oncology 47 (2), 97-183, 2013
572013
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
E Derenzini, MP Fina, V Stefoni, C Pellegrini, F Venturini, A Broccoli, ...
Annals of oncology 21 (6), 1173-1178, 2010
562010
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review
F Alongi, B De Bari, F Campostrini, S Arcangeli, DV Matei, E Lopci, ...
Critical reviews in oncology/hematology 88 (3), 550-563, 2013
552013
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR
E Lopci, A Piccardo, C Nanni, V Altrinetti, A Garaventa, A Pession, ...
Clinical nuclear medicine 37 (4), e73-e78, 2012
542012
FDG PET/CT for assessing tumour response to immunotherapy
N Aide, RJ Hicks, C Le Tourneau, S Lheureux, S Fanti, E Lopci
European journal of nuclear medicine and molecular imaging 46 (1), 238-250, 2019
502019
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
E Lopci, M Riva, L Olivari, F Raneri, R Soffietti, A Piccardo, A Bizzi, ...
European journal of nuclear medicine and molecular imaging 44 (7), 1155-1164, 2017
482017
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC …
FE Lecouvet, DE Oprea-Lager, Y Liu, P Ost, L Bidaut, L Collette, ...
The Lancet Oncology 19 (10), e534-e545, 2018
432018
The role of 18F‐FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma
A Cistaro, E Lopci, L Gastaldo, P Fania, A Brach del Prever, F Fagioli
Pediatric Blood & Cancer, 2012
402012
FDG PET/CT predictive role in follicular lymphoma
E Lopci, L Zanoni, A Chiti, C Fonti, I Santi, PL Zinzani, S Fanti
European journal of nuclear medicine and molecular imaging 39 (5), 864-871, 2012
402012
Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma
A Piccardo, M Puntoni, E Lopci, M Conte, L Foppiani, S Sorrentino, ...
European journal of nuclear medicine and molecular imaging 41 (6), 1046-1056, 2014
342014
Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies
E Lopci, A Chiti, MR Castellani, G Pepe, L Antunovic, S Fanti, ...
European journal of nuclear medicine and molecular imaging 38 (1), 28, 2011
332011
PET/CT imaging in neuroblastoma.
A Piccardo, E Lopci, M Conte, L Foppiani, A Garaventa, M Cabria, ...
The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official …, 2013
312013
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma
P Navarria, G Reggiori, F Pessina, AM Ascolese, S Tomatis, P Mancosu, ...
Radiotherapy and Oncology 112 (3), 425-429, 2014
302014
Usefulness of 64Cu-ATSM in head and neck cancer: a preliminary prospective study
I Grassi, C Nanni, G Cicoria, C Blasi, F Bunkheila, E Lopci, PM Colletti, ...
Clinical nuclear medicine 39 (1), e59-e63, 2014
302014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20